Are There Any Long-Term Safety Considerations for Peptide Therapies for Sexual Function?
Peptide therapies for sexual function, like bremelanotide, demonstrate a favorable safety profile in clinical trials up to 76 weeks, with ongoing research into longer-term effects.
HRTioJuly 19, 2025